Graham Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-569
| Closed | -$229K | – | 1513 |
|
|
2024
Q4 | $229K | Buy |
+569
| New | +$229K | ﹤0.01% | 1007 |
|
|
2024
Q2 | – | Sell |
-2,357
| Closed | -$985K | – | 1369 |
|
|
2024
Q1 | $985K | Buy |
2,357
+530
| +29% | +$222K | 0.02% | 406 |
|
|
2023
Q4 | $743K | Buy |
+1,827
| New | +$743K | 0.02% | 442 |
|
|
2023
Q3 | – | Sell |
-1,144
| Closed | -$403K | – | 1296 |
|
|
2023
Q2 | $403K | Buy |
+1,144
| New | +$403K | 0.01% | 595 |
|
|
2022
Q4 | – | Sell |
-14,195
| Closed | -$4.11M | – | 1366 |
|
|
2022
Q3 | $4.11M | Sell |
14,195
-88
| -0.6% | -$25.5K | 0.16% | 60 |
|
|
2022
Q2 | $4.02M | Buy |
14,283
+11,624
| +437% | +$3.27M | 0.16% | 71 |
|
|
2022
Q1 | $693K | Buy |
2,659
+223
| +9% | +$58.1K | 0.02% | 430 |
|
|
2021
Q4 | $534K | Buy |
+2,436
| New | +$534K | 0.02% | 152 |
|